Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia.

MLA

Döhner, Konstanze, et al. “Impact of NPM1/FLT3-ITD Genotypes Defined by the 2017 European LeukemiaNet in Patients with Acute Myeloid Leukemia.” Blood, vol. 135, no. 5, Jan. 2020, pp. 371–80. EBSCOhost, https://doi.org/10.1182/blood.2019002697.

APA

Döhner, K., Thiede, C., Jahn, N., Panina, E., Gambietz, A., Larson, R. A., Prior, T. W., Marcucci, G., Jones, D., Krauter, J., Heuser, M., Voso, M. T., Ottone, T., Nomdedeu, J. F., Mandrekar, S. J., Klisovic, R. B., Wei, A. H., Sierra, J., Sanz, M. A., … Bloomfield, C. D. (2020). Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia. Blood, 135(5), 371–380. https://doi.org/10.1182/blood.2019002697

Chicago

Döhner, Konstanze, Christian Thiede, Nikolaus Jahn, Ekaterina Panina, Agnes Gambietz, Richard A Larson, Thomas W Prior, et al. 2020. “Impact of NPM1/FLT3-ITD Genotypes Defined by the 2017 European LeukemiaNet in Patients with Acute Myeloid Leukemia.” Blood 135 (5): 371–80. doi:10.1182/blood.2019002697.